Parion Sciences Receives NIH Biodefense Grant To Study Novel Methods For Mitigating Radiation-Induced Lung Injury (Medical News Today)

Parion Sciences, Inc., a privately-held, development-stage pharmaceutical company dedicated to treating diseases resulting from the failure of the body's mucosal defenses, today announced that the National Institutes of Health (NIH) have awarded the company a biodefense grant in excess of $850,000.

Durham Pharmaceutical Company Awaded National Institutes of Health Grant (MyNC.com)

Parion Sciences, a development-stage pharmaceutical company announced the National Institutes of Health (NIH) have awarded the company a biodefense grant in excess of $850,000.

Parion Sciences Gets Grant To Study Radiation-Induced Lung Injuries (MyNC.com)

Parion Sciences, Inc., a privately-held, development-stage pharmaceutical company dedicated to treating diseases resulting from the failure of the body’s mucosal defenses, Wednesdsay announced that the National Institutes of Health (NIH) have awarded the company a biodefense grant in excess of $850,000.

Immunology Center Will Continue To Drive Standard Methods, Better Science (Medical News Today)

The Rochester Human Immunology Center (RHIC) has been awarded a $4 million renewal of its grant from the National Institute of Allergy and Infection Disease (NIAID). The renewal enables RHIC to continue leading the field of immunology in a worldwide effort to standardize how researchers use complex technologies like flow cytometry that are central to the discovery of new treatments.

Immunology Center will continue to drive standard methods, better science (EurekAlert!)

( University of Rochester Medical Center ) The Rochester Human Immunology Center has been awarded a $4 million renewal of its grant from the National Institute of Allergy and Infection Disease. The renewal enables RHIC to continue leading the field of immunology in a worldwide effort to standardize how researchers use complex technologies like flow cytometry that are central to the discovery of ...